Prostate‐specific antigen nadir within 12 months as an early surrogate marker of biochemical failure and distant metastasis after low‐dose‐rate brachytherapy or external beam radiotherapy for localized prostate cancer

Lignende værker

• Combination of 5α-reductase inhibitor with combined androgen blockade (CAB) as a novel cytoreductive regimen before prostate brachytherapy: Ultra-CAB
  af: Muro, Yusuke, et al.
  Udgivet: (2015)
• Plan reproducibility of intraoperatively custom-built linked seeds compared to loose seeds for prostate brachytherapy
  af: Kaneda, Tomoya, et al.
  Udgivet: (2018)
• Dosimetric effects of prone and supine positions on post-implant assessments for prostate brachytherapy
  af: Ohashi, Toshio, et al.
  Udgivet: (2013)
• Comparison of prostate verification with implanted gold markers in tissue surrounding the prostate and pelvic bony anatomy for external beam radiation therapy following low-dose-rate brachytherapy: a prospective clinical trial
  af: Kaneda, Tomoya, et al.
  Udgivet: (2020)
• Predicting pubic arch interference in prostate brachytherapy on transrectal ultrasonography-computed tomography fusion images
  af: Fukada, Junichi, et al.
  Udgivet: (2012)